Market News
Stay updated with the latest market trends, earnings, and economic indicators.
Sun Pharmaceutical among 5 Nifty stocks showing bullish RSI upswing
Five Nifty50 stocks featured in the RSI Trending Up scan on June 17 after showing improving momentum. The RSI moved above the 50 mark from lower levels, signalling strengthening price action, improving sentiment and potential short-term buying opportunities for traders tracking bullish technical setups.
Stocks to Watch today: RVNL, HFCL, Gujrat Gas, Hudco, Lupin, Hexware Tech
Stock to Watch today, June 18: ZF Commercial Vehicle Control Systems India, Lemon Tree Hotels, Anik Industries, and Balkrishna Industries are among the top stocks to remain in focus
HDFC MF, ADIA among buyers as Sepia Investments offloads Rs 749 crore in Corona Remedies via block deal
Sepia Investments and Anchor Partners sold shares worth about Rs 777 crore in Corona Remedies through block deals. HDFC Mutual Fund emerged as the largest buyer, while several institutional investors, including Aberdeen entities, ADIA, Invesco and WhiteOak, also accumulated stakes.
Public-private projects key to expand access to Kidney care: NephroPlus
NephroPlus, India's leading provider of dialysis services, is on a mission to reshape the future of kidney health with an innovative tech-based platform aimed at preventing chronic kidney disease. As it scales up its network of dialysis centers both domestically and in global markets, this forward-thinking initiative seeks to combat the advancement of kidney ailments.
Fast-tracked power plants fuel AI boom, with little public scrutiny
New power plants are being built at an unprecedented speed to meet the growing demand of tech companies. These facilities, often fueled by natural gas, are being approved with minimal public notice and environmental review. Residents are raising alarms about potential health and climate impacts. This trend is reshaping energy infrastructure across the United States.
Thursday’s insider buys and sells: Healthcare and tech in focus By Investing.com - Investing.com India
Thursday’s insider buys and sells: Healthcare and tech in focus By Investing.comInvesting.com India
AB Group reaffirms bet on Voda Idea with ₹4,730 Cr infusion
Vodafone Idea shareholders approved a ₹4,730-crore investment from the Aditya Birla Group via preferential allotment of warrants, increasing AB Group's stake to around 13%. Chairman Kumar Mangalam Birla stated the company's focus now shifts to execution across operations, customer service, and network expansion. This capital infusion will support capital expenditure and loan repayment, reinforcing Vi's financial health.
Market Trading Guide: Akums Drugs among 4 stock recommendations for Thursday
Domestic equities ended lower amid global uncertainty and caution ahead of key US inflation data. Despite market weakness, analysts remain bullish on Akums Drugs and Aditya Birla Sun Life AMC after strong technical breakouts, rising volumes and improving momentum indicators.
Panacea Biotec Ltd leads losers in 'B' group
Agri-Tech (India) Ltd, Orbit Exports Ltd, Shardul Securities Ltd and Creative Eye Ltd are among the other losers in the BSE's 'B' group today, 10 June 2026.
Stock Alert: KRN Heat, Patanjali Foods, Bharti Airtel, Dixon Tech, Glenmark Pharma, Bharti Hexacom
Securities in F&O Ban:
Five Stocks To Buy: Dixon Tech, Belrise Industries, Marksans Pharma And More | June 10, 2026
Top picks include blue-chip electronics manufacturers, expanding auto components players, mid-tier pharma exporters, and major private and public sector banking stocks.
PE investor BC Investments sells Rs 612 crore stake in Emcure Pharma; Kotak MF picks up stake
Private equity firm BC Investments IV sold a Rs 612 crore stake in Emcure Pharmaceuticals to Kotak Mahindra Mutual Fund at Rs 1,700 per share. Despite this divestment, analysts remain positive on Emcure's growth outlook across its core therapeutic segments.